Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PH0N | ISIN: CA2524423068 | Ticker-Symbol: 4D4A
Frankfurt
13.05.26 | 08:08
0,116 Euro
+3,57 % +0,004
1-Jahres-Chart
DIAGNOS INC Chart 1 Jahr
5-Tage-Chart
DIAGNOS INC 5-Tage-Chart

Aktuelle News zur DIAGNOS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.04.Diagnos Inc (3): Diagnos 5,228,668 warrants extended1
09.04.Diagnos Inc (3): Diagnos talks regulatory progress for Cara 1
08.04.DIAGNOS Inc.: DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA99BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related...
► Artikel lesen
02.04.Diagnos Inc (3): Diagnos completes medical device establishment renewal1
DIAGNOS Aktie jetzt für 0€ handeln
01.04.DIAGNOS Inc.: DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration176BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related...
► Artikel lesen
31.03.Diagnos Inc (3): Diagnos replacement convertible debentures1
06.03.Diagnos Inc (3): Diagnos to amend convertible debenture, warrant terms1
05.03.DIAGNOS Inc.: DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants1
05.02.Diagnos Inc (3): Diagnos expects to receive $1M in federal investments1
04.02.DIAGNOS Inc.: DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation1
16.01.Diagnos Inc (3): Diagnos hires Investor Brand Network for communication1
15.01.DIAGNOS Inc.: DIAGNOS Announces the Engagement of IBN1
14.01.Diagnos Inc (3): Diagnos talks regulatory progress for CARA1
13.01.DIAGNOS Inc.: DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress4
19.12.25Diagnos Inc (3): Diagnos 13,337,262-share private placement1
17.12.25Diagnos Inc (3): Diagnos appoints Ben Ayed as chief AI scientist1
16.12.25DIAGNOS Inc.: DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare245BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence...
► Artikel lesen
11.12.25Diagnos Inc (3): Diagnos 4,627,931 warrants extended1
09.12.25DIAGNOS Inc.: Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital1
26.11.25Diagnos Inc (3): Diagnos increases financing to $3.65-million1
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1